Effect of L-dopa administration on growth hormone secretion in normal subjects and Parkinsonian patients.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D001120:Arginine; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004298:Dopamine / Q000502:physiology; D005260:Female; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007275:Injections, Intravenous; D007328:Insulin; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D012636:Secretory Rate / Q000187:drug effects
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D007328:Insulin; D004295:Dihydroxyphenylalanine; D013006:Growth Hormone; D001120:Arginine; D004298:Dopamine